TURK ILAC SERUMTURK ILAC SERUMTURK ILAC SERUM

TURK ILAC SERUM

No trades
See on Supercharts

TRILC fundamentals

TURK ILAC SERUM financial statements, including revenue, expenses, profit, and loss

The total revenue of TRILC for the last quarter is 465.55 M TRY, and it's 37.53% lower compared to the previous quarter. The net income of Q3 24 is 1.29 M TRY.

Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: TRY
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth